Up-date on renal fibrosis: a time for action.
Wardle
E Nigel
EN
D049109:Cell Proliferation / Q000187:drug effects; D018450:Disease Progression; D005109:Extracellular Matrix / Q000187:drug effects / Q000473:pathology; D005355:Fibrosis / Q000473:pathology / Q000517:prevention & control; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000473:pathology / Q000517:prevention & control*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011355:Prodrugs; D011379:Prognosis
D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D011355:Prodrugs; D009173:Mycophenolic Acid; D005905:Glyburide